Generic Biopharmaceuticals
China Medical Technologies (Nasdaq: CMED)
Medical Devices and Supplies
Tongjitang Chinese Medicines (NYSE: TCM)
Traditional Chinese Medicine, Supplements
Digging in and doing research China's health-care plans are still in the early stages, but history shows that health-care spending tends to ramp up quickly as emerging economies develop. Based on the U.N. population growth assumptions, it looks like China will need to quickly make this transition, too.
The growth potential in health care is one reason our Motley Fool Global Gains team is headed back to China this week to meet with some promising companies we've identified through our research. If you're interested in hearing about what we find, you can sign up to receive all of our free real-time dispatches from the field simply by providing your email address in the box below.
Nathan Parmalee is a Motley Fool contributor.
Be the first to read Nathan Parmalee's column. Sign up today and receive Townhall.com delivered each morning to your inbox.